Global point of care
ADVANCING HEPATITIS ELIMINATION THROUGH INTEGRATED TESTING
Summary
Viral hepatitis remains a leading cause of preventable mortality despite the availability of effective testing, prevention, and treatment tools. Closing this gap requires integrated strategies to expand diagnosis and strengthen linkage to care. This panel discussion brings together experts to share real-world lessons on scaling hepatitis testing and integrating services across primary care, antenatal, and HIV/STI platforms.
Watch now to gain insights into concrete policy actions that can drive measurable impact towards hepatitis elimination goals.
This session was presented at the World Hepatitis Summit 2026 in Bangkok, Thailand.
Learning Objectives
- Understand key strategies to scale hepatitis testing and linkage to care in priority populations.
- Explore country experiences implementing integrated hepatitis services in real world settings.
- Identify practical enablers for advancing elimination at local, regional, and national levels.
Disclaimer: Speakers have been engaged by the APAC Liver Disease Alliance, and the session is supported by Abbott.
Presenter Biography
Bethany Holt, MD, MPH
Director of Health Systems Transformation and Partnerships
Program in Global Primary Health Care
Brigham and Women’s Hospital and Harvard Medical School
Chatree Jullapetch, MD
Head, Viral Hepatitis Coordination Center
Department of Disease Control
Ministry of Public Health, Thailand
Cary James
CEO, World Hepatitis Alliance
Roberta Sarno, Moderator
Director, APAC Liver Disease Alliance
Who Should Watch
Healthcare Professionals, Policy Makers, Program Implementers